{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:16:40Z","timestamp":1782947800170,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T00:00:00Z","timestamp":1718668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.seizure.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:20:48Z","timestamp":1718407248000},"page":"56-60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Association of UGT1A6 gene polymorphisms with sodium valproate-induced tremor in patients with epilepsy"],"prefix":"10.1016","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5263-8008","authenticated-orcid":false,"given":"Zheng","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2024.06.008_bib0001","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.parkreldis.2016.02.002","article-title":"Tremor pattern differentiates drug-induced resting tremor from Parkinson disease","volume":"25","author":"Nistic\u00f2","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.seizure.2024.06.008_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.576579","article-title":"Risk of valproic acid-related tremor: a systematic review and meta-analysis","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.seizure.2024.06.008_bib0003","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","article-title":"Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review","volume":"31","author":"Silva","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"10.1016\/j.seizure.2024.06.008_bib0004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40291-013-0041-8","article-title":"The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach","volume":"17","author":"Munisamy","year":"2013","journal-title":"Mol Diagn Ther"},{"issue":"9","key":"10.1016\/j.seizure.2024.06.008_bib0005","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2217\/pgs.12.78","article-title":"Functional impact and prevalence of polymorphisms involved in the hepatic glucuronidation of valproic acid","volume":"13","author":"Chatzistefanidis","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"3","key":"10.1016\/j.seizure.2024.06.008_bib0006","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1124\/jpet.104.081950","article-title":"UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5\u2032-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation","volume":"313","author":"Krishnaswamy","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.seizure.2024.06.008_bib0007","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"19","key":"10.1016\/j.seizure.2024.06.008_bib0008","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJMcp1707928","article-title":"Essential tremor","volume":"378","author":"Haubenberger","year":"2018","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.seizure.2024.06.008_bib0009","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mds.21412","article-title":"Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor","volume":"22","author":"Stacy","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.seizure.2024.06.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107628","article-title":"Essential tremor and the scales: quality of life in essential tremor, the Fahn-Tolosa-Marin Tremor Rating Scale; and, the Bain and findley clinical tremor rating scale","volume":"226","author":"Serrano-Due\u00f1as","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"10.1016\/j.seizure.2024.06.008_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug Metabolism in the Liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.seizure.2024.06.008_bib0012","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1124\/dmd.31.1.133","article-title":"Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6","volume":"31","author":"Krishnaswamy","year":"2003","journal-title":"Drug Metabol Disposit Biol Fate of Chem"},{"issue":"1","key":"10.1016\/j.seizure.2024.06.008_bib0013","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0090-9556(25)07335-0","article-title":"Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family","volume":"21","author":"Ebner","year":"1993","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.seizure.2024.06.008_bib0014","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13049-017-0382-0","article-title":"Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6\/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury","volume":"25","author":"Sun","year":"2017","journal-title":"Scand J Trauma Resusc Emerg Med"},{"issue":"8","key":"10.1016\/j.seizure.2024.06.008_bib0015","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00204-020-02765-8","article-title":"Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors","volume":"94","author":"Kasteel","year":"2020","journal-title":"Arch Toxicol"},{"issue":"1","key":"10.1016\/j.seizure.2024.06.008_bib0016","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/metabo13010134","article-title":"Therapeutic and toxic effects of valproic acid metabolites","volume":"13","author":"Shnayder","year":"2023","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.seizure.2024.06.008_bib0017","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2217\/pgs.11.64","article-title":"Association of genetic variants in six candidate genes with valproic acid therapy optimization","volume":"12","author":"Hung","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.seizure.2024.06.008_bib0018","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00213-021-06004-5","article-title":"Investigation of the risk of valproic acid-induced tremor: clinical, neuroimaging, and genetic factors","volume":"239","author":"Lan","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"47","key":"10.1016\/j.seizure.2024.06.008_bib0019","doi-asserted-by":"crossref","first-page":"e8711","DOI":"10.1097\/MD.0000000000008711","article-title":"Disabling tremor induced by long-term use of sodium valproate and lamotrigine: case report","volume":"96","author":"He","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.seizure.2024.06.008_bib0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2133\/dmpk.DMPK-11-NT-144","article-title":"Effects of UGT1A6, UGT2B7, and CYP2C9 genotypes on plasma concentrations of valproic acid in Chinese children with epilepsy","volume":"27","author":"Guo","year":"2012","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"10.1016\/j.seizure.2024.06.008_bib0021","first-page":"475","article-title":"Syndrome parkinsonien d\u00fb aux m\u00e9dicaments [Drug-induced parkinsonism]","volume":"70","author":"Ory-Magne","year":"2020","journal-title":"Rev Prat"},{"key":"10.1016\/j.seizure.2024.06.008_bib0022","first-page":"397","article-title":"Drugs and pharmaceuticals: management of intoxication and antidotes","volume":"100","author":"Smith","year":"2010","journal-title":"EXS"},{"key":"10.1016\/j.seizure.2024.06.008_bib0023","first-page":"96","article-title":"Drug-induced Parkinsonism","volume":"13","author":"Vaiman","year":"2021","journal-title":"Soc Clin Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.seizure.2024.06.008_bib0024","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF03190383","article-title":"Establishing individual metabolite patterns for patients on valproate therapy","volume":"26","author":"Kreher","year":"2001","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"5","key":"10.1016\/j.seizure.2024.06.008_bib0025","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mdc3.12324","article-title":"A complex hyperkinesia induced by valproate","volume":"3","author":"Bruno","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.seizure.2024.06.008_bib0026","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.parkreldis.2017.09.011","article-title":"The clinical features and functional impact of valproate-induced tremor","volume":"44","author":"Alonso-Juarez","year":"2017","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124001699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131124001699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:10:25Z","timestamp":1762362625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131124001699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"alternative-id":["S1059131124001699"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2024.06.008","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of UGT1A6 gene polymorphisms with sodium valproate-induced tremor in patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}